SLS Stock Logs Best Day In Over 2 Weeks: Citigroup Builds Nearly $5M Stake Ahead Of Key AML Trial Trigger
Sellas Life Sciences (SLS) stock experienced its best day in over two weeks, jumping 12% after Citigroup disclosed a nearly $5 million stake. This increased investor interest comes as the biotech firm approaches a key Phase 3 acute myeloid leukemia (AML) trial catalyst, with …
Sharemaestro market context Trend signal active 52 weeks +48.6% · Next-week setup positive 60.8%